Patients evaluating their own eligibility should treat published BMI thresholds the same way: as the beginning of a clinical conversation, not the end of one
Effect of probiotics on respiratory tract allergic disease and gut microbiota
Jonathan Paul Mochel, Iowa State University, United States Updates Copyright 2021 Puglisi, Rossini, Poli, Dughera, Pia, Terzolo and Reimondo
Patients with genetic markers suggesting slower GLP-1 receptor responsiveness may benefit from more gradual dose increases, while those with rapid-adapter genetics might tolerate faster escalation with fewer interim side effects
Acknowledgements This study was supported by grants from the Chang Gung Memorial Foundation (CMRPG-5D0111, CMRPG2F0171, CMRPG2F0172, CMRPG2F0173, CMRPG-2G0361, CMRPG-2H0161, CRRPG2H0162, CMRPG-2J0261, CMRPG-2K0091, CORPG2N0141, CORPG2P0231, and CORPG2P0191), the Ministry of Science and Technology, Taiwan (104-2320-B-182A-013, 106-2314-B-182A-064, 107-2314-B-182A-138, 108-2320-B-182A-009-MY3, 108-2314-B-182A-027, 108-2321-B-182-003 and 109-2321-B-182-001) and the Taiwanese Ministry of Health and Welfare (MOHW110-TDU-B-212-124005, MOHW111-TDU-B-212-134005, MOHW112-TDU-B-212-144005)